Clinical Significance of CSF Glutamate Concentrations Following Severe Traumatic Brain Injury in Humans

Journal of Neurotrauma

Volumn 15, Issue 4, 1998, Pages 253-263

  Brown, Jennifer I m ^a   Baker, Andrew J ^a   Konasiewicz, Stefan J ^a   Moulton, Richard J ^a,b  

^a Department of Surgery ^*  (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

cerebral ischemia; clinical outcome; glutamate; temporal pattern; traumatic brain injury

Indexed keywords

EID: 85009295914     PISSN: 08977151     EISSN: 15579042     Source Type: Journal    
DOI: 10.1089/neu.1998.15.253     Document Type: Article

References (41)

1. ALBERICO, A.M., WARD, J.D., and CHOI SUNG, C. (1987). Outcome after severe head injury. Relationship to mass lesions, diffuse injury, and ICP course in pediatric and adult patients. J. Neurosurg. 67, 648–656.
2. ATTWELL, D., BARBOUR, B., and SZATKOWSKI, M. (1993). Nonvesicular release of neurotransmitter. Neuron 11, 401–407.
3. AUER, R.N., and SIESÖ, B.K. (1988). Biological differences between ischemia, hypoglycemia, and epilepsy. Ann. Neural. 24, 699–707.
4. BAKER, A.J., ZORNOW, M.H., SCHELLER, M.S. et al. (1991). Changes in extracellular concentrations of glutamate, aspartate, glycine, dopamine, serotonin, and dopamine metabolites after transient global ischemia in the rabbit brain. J. Neurochem. 57, 1370–1379.
5. BAKER, A.J., MOULTON, R.J., MACMILLAN, V.H., and SHEDLEN, P.M. (1993). Excitatory amino acids in cerebrospinal fluid following traumatic brain injury in humans. J. Neurosurg. 79(3):369–372.
6. BAKER, C.J., FIORE, A.J., and FRAZZINI, V.I. (1995). Intraischemic hypothermia decreases the release of glutamate in the cores of permanent focal cerebral infarcts. Neurosurg. 36, 994–1002.
7. BONDOLI, A., BARBI, S., CAMAIONI, D., DELLA MORTE, F., and MAGALINI, S.I. (1981). Plasma and cerebrospinal fluid free amino acid concentration in post-traumatic cerebral oedema in patients with shock. Resuscitation 9,119–124.
8. BULLOCK, R., and FUJISAWA, H. (1992). The role of glutamate antagonists for the treatment of CNS injury. J. Neurotrauma 9, S443-S462.
9. BULLOCK, R., ZAUNER, A., MYSEROS, J.S., MARMAROU, A., WOODWARD, J.J., and YOUNG, H.F. (1995). Evidence for prolonged release of excitatory amino acids in severe human head trauma. Relationship to clinical events. Ann. NY Acad. Sci. 765, 290–297.
10. CHESTNUT, R.M., GAUTILLE, T., BLUNT, B.A., and KLAUBER, M.R. (1994). The localizing value of asymmetry in pupillary size in severe head injury: Relation to lesion type and location. Neurosurg. 34, 840–846.
11. CHOI, D.W., MAULUCCI-GEDDE, M., and KRIEGSTEIN, A.R. (1987). Glutamate neurotoxicity in cortical cell culture. J. Neurosci. 7, 357–368.
12. DAVSON, H. (1967). Physiology of the cerebrospinal fluid. Boston: Little, Brown & Co.
13. FADEN, A.I., DEMEDIUK, P., PANTER, S.S., and VINK, R. (1989). The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 244, 798–800.
14. FADEN, A.I., and SALZMAN, S. (1992). Pharmacological strategies in CNS trauma. Trends Pharmacol. Sci. 13, 29–35.
15. FERRARESE, C., PECORA, N., FRIGO, M., APPOLLONIO, I., and FRATTOLA, L. (1993). Assessment of reliability of biological significance of glutamate levels in cerebrospinal fluid. Ann. Neural. 33, 316–319.
16. GENNARELLI, T.A. (1993). Cerebral concussion and diffuse brain injuries. In Head injury. P.R. Cooper (ed.). Williams and Wilkins, Baltimore, pp. 1–25.
17. GENTILE, N.T., and MCINTOSH, T.K. (1993). Antagonists of excitatory amino acids and endogenous opioid peptides in the treatment of experimental brain injury. Ann. Emerg. Med. 22, 1028–1034.
18. HAYES, R.L., JENKINS, L.W., and LYETH, B.G. (1992). Neurotransmitter-mediated mechanisms of traumatic brain injury: Acetylcholine and excitatory amino acids. J. Neurotrauma 9, Suppl 1, S173-S187.
19. HOVDA, D.A., LEE, S.M., and SMITH, M.L. (1995). The neurochemical and metabolic cascade following brain injury: Moving from animal models to man. J. Neurotrauma 12, 903–906.
20. JENNETT, B., TEASDALE, G., BRAAKMAN, R., MINDERHOUD, J., and KNILL-JONES, R. (1976). Predicting outcome in individual patients after severe head injury. Lancet 1, 1031–1034.
21. JENNETT, B., TEASDALE, G., and GALBRAITH, S. (1977). Severe head injury in three countries. J. Neurol. Neurosurg. Psychiatry 49, 291–298.
22. KANTHAN, R., SHUAIB, A., GRIEBEL, R., MIYASHITA, H., and KALRA, J. (1996). Glucose-induced decrease in glu-tamate levels in ischemic human brain by in vivo microdialysis. Neurosci. Lett. 209(3):207–209.
23. KATAYAMA, Y., BECKER, D.P., TAMURA, T., and HOVDA, D.A. (1990). Massive increases in extracellular potassium and the indiscriminate release of glutamate following concussive brain injury. J. Neurosurg. 73, 889–900.
24. KEMPSKI, O., VON ANDRIAN, U., SCHURER, L., and BAETHMANN, A. (1990). Intravenous glutamate enhances edema formation after a freezing lesion. Adv. Neurol. 52, 219–223.
25. KONASIEWICZ, S.J., and MOULTON, R.J. (1994). Electrophysiologic assessment of intracerebral contusions in closed head injury. J. Trauma 37, 370–374.
26. LYLE, D.M., PIERCE, J.P., and FREEMAN, E.A. (1986). Clinical course and outcome of severe head injury in Australia. J. Neurosurg. 65, 15–18.
27. MCINTOSH, T.K. (1992). Pharmacologic strategies in the treatment of experimental brain injury. J. Neurotrauma 9 Suppl 1, S201-S209.
28. MCINTOSH, T.K., VINK, R., SOARES, H., HAYES, R., and SIMON, R. (1989). Effects of the N-methyl-D-aspartate receptor blocker MK-801 on neurologic function after experimental brain injury. J. Neurotrauma 6, 247–259.
29. MCINTOSH, T.K., VINK, R., SOARES, H., HAYES, R., and SIMON, R. (1990). Effect of noncompetitive blockade of N-methyl-D-aspartate receptors on the neurochemical sequelae of experimental brain injury. J. Neurochem. 55, 1170–1179.
30. MOULTON, R., KRESTA, P., RAMIREZ, R., and TUCKER, W. (1991). Continuous automated monitoring of somatosensory evoke potentials in posttraumatic coma. J. Trauma 31, 676–685.
31. PANTER, S.S., and FADEN, A.I. (1992). Pretreatment with NMDA antagonists limits release of excitatory amino acids following traumatic brain injury. Neurosci. Lett. 136, 165–168.
32. REGAN, R.F., and CHOI, D.W. (1994). Excitotoxicity and central nervous system trauma. In The neurobiology of central nervous system trauma. S.K. Salzman and A.I. Faden (eds.). Oxford University Press, Inc., New York, pp. 173–181.
33. ROBERTSON, C.S., GOPINATH, S.P., and GOODMAN, J.C. (1995). SjvO2 monitoring in head-injured patients. J. Neurotrauma 12, 891–896.
34. SHEDDEN, P.M., MOULTON, R.J., SULLIVAN, I., HOTZ, G., TUCKER, W.S., and MULLER, P.J. (1990). Effect of population characteristics on head injury mortality. Pediatr. Neurosurg. 16, 203–207.
35. SHUAIB, A., KANTHAN, R., GOPLEN, G., GRIEBEL, R., EL-AZZOUNI, H., MIYASHITA, H., LIU, L., HOGAN, T. (1996). In vivo microdialysis study of extracellular glutamate response to temperature variance in subarachnoid hemorrhage. Acta Neurochirurgica-Suppl. 67, 53–58.
36. SZATKOWSKI, M., and ATTWELL, D. (1994). Triggering and execution of neuronal death in brain ischaemia: Two phases of glutamate release by different mechanisms. TINS 17, 359–365.
37. TSUCHIDA, E., and BULLOCK, R. (1995). The effect of the glycine site-specific N-methyl-D-aspartate antagonist ACEA 1021 on ischaemic brain damage caused by acute subdural haematoma in the rat. J. Neurotrauma 12, 279–288.
38. WINFREE, C.J., BAKER, C.J., CONNOLLY, E.S., FIORE, A.J., and SOLOMON, R.A. (1996). Mild hypothermia reduces penumbral glutamate levels in the rat permanent focal cerebral ischemia model. Neurosurg. 38, 1216–1217.
39. ZAUNER, A., and BULLOCK, R. (1995). The role of excitatory amino acids in severe brain trauma: Opportunities for therapy: A review. J. Neurotrauma 12, 547–554.
40. ZAUNER, A., BULLOCK, R., KUTA, A.J., WOODWARD, J., and YOUNG, H.F. (1996). Glutamate release and cerebral blood flow after severe human head injury. Acta Neurochirurgica Suppl. 67, 40–44.
41. ZORNOW, M.H. (1995). Inhibition of glutamate release: A possible mechanism of hypothermie neuroprotection. J. Neurosurg. Anesthesiol. 7, 148–151.